Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Elanix Biotechnologies

Elanix Biotechnologies
2012 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
ELN STOCK SYMBOL
$0.48 SHARE PRICE (As of Monday Closing)
Description

Elanix Biotechnologies AG is a tissue regeneration company. It develops and commercializes products for acute wound care, dermatological and gynecological applications as well as providing cell technology services. The company's operating segment include Regenerative Medicine and Cosmetic ointments. It generates maximum revenue from the Cosmetic ointments segment. Geographically, it derives a majority of revenue from Switzerland and also has a presence in the EU, and Taiwan.

Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
FRA
Primary Office
  • Route de la Corniche 4
  • Biopole
  • 1066 Epalinges
  • Switzerland
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Elanix Biotechnologies’s full profile, request a free trial.

Elanix Biotechnologies Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.41 - $2.79 $3.85M $0.43 -$14.74 6.02K

Elanix Biotechnologies Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 12,162 12,162 22,645 27,444
Revenue 73 73 256 7
EBITDA (4,066) (4,066) (3,917) (2,568)
Net Income (4,402) (4,402) (3,378) (2,091)
Total Assets 1,233 1,233 2,958 22,933
Total Debt 0 0 202 542
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Elanix Biotechnologies Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Elanix Biotechnologies‘s full profile, request access.

Request full access to PitchBook

Elanix Biotechnologies Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Elanix Biotechnologies‘s full profile, request access.

Request full access to PitchBook

Elanix Biotechnologies Executive Team (4)

Name Title Board
Seat
Contact
Info
Lee Ann Applegate Ph.D Interim Chief Executive Officer
Egon Minar Chief Operating Officer & Chief Financial Officer

2 Former Executives

You’re viewing 2 of 4 executives. Get the full list »